Skip to main content
Erschienen in: World Journal of Surgery 1/2020

24.09.2019 | Original Scientific Report

Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study

verfasst von: Dong Tian, Heng Huang, Yu-Shang Yang, Kai-Yuan Jiang, Xi He, Xiao-Guang Guo, Long-Qi Chen

Erschienen in: World Journal of Surgery | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Although a greater depth of tumor invasion is correlated with a poorer prognosis in esophageal squamous cell carcinoma (ESCC), it remains controversial whether T2 ESCC should be subclassified by circular and longitudinal muscle invasion. We conducted a multicenter retrospective study to evaluate the relationship between the depth of invasion and long-term outcome and to identify the clinical significance of subclassifying T2 ESCC.

Methods

Patients with T2 ESCC who underwent esophagectomy at two different institutes between January 2009 and December 2017 were analyzed retrospectively. ESCC with circular and longitudinal muscle invasion was defined as T2 circular and T2 longitudinal ESCC, respectively. Survival outcomes and risk factors for lymph node metastasis (LNM) were evaluated by univariate and multivariate analyses. In addition, data from stage T1b ESCC cases during the same period were retrieved for use as a comparison cohort to evaluate the prognostic significance of the T2 substage.

Results

A total of 536 T2 ESCC patients were eligible, and 192 (36%) patients developed LNM. No significant difference was found in general characteristics between the T2 circular and T2 longitudinal ESCC groups (n = 219 and n = 317, P > 0.05), except for tumor location (P = 0.02). The T2 substage was not significantly correlated with survival on univariate or multivariate analysis (P = 0.30 and P = 0.34, respectively). Multivariate analysis also indicated that the T2 substage was not an independent risk factor for LNM (P = 0.15). When patients with stage T1b ESCC were considered, their survival time was significantly different from that of patients with T2 circular and T2 longitudinal disease (P = 0.01).

Conclusions

The depth of tumor invasion into the circular and longitudinal muscle layers in T2 ESCC does not affect the prognosis or risk of LNM.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRef Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRef
2.
Zurück zum Zitat Tian D, Mo SJ, Han LK et al (2018) Investigation of dietary factors and esophageal cancer knowledge: comparison of rural residents in high- and low-incidence areas. Sci Rep 8:4914CrossRef Tian D, Mo SJ, Han LK et al (2018) Investigation of dietary factors and esophageal cancer knowledge: comparison of rural residents in high- and low-incidence areas. Sci Rep 8:4914CrossRef
3.
Zurück zum Zitat Zhang JQ, Hooker CM, Brock MV, et al (2012) Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg 93:429–435CrossRef Zhang JQ, Hooker CM, Brock MV, et al (2012) Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg 93:429–435CrossRef
4.
Zurück zum Zitat Dolan JP, Kaur T, Diggs BS et al (2016) Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy. Dis Esophagus 29:320–325CrossRef Dolan JP, Kaur T, Diggs BS et al (2016) Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy. Dis Esophagus 29:320–325CrossRef
5.
Zurück zum Zitat Crabtree TD, Kosinski AS, Puri V et al (2013) Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the society of thoracic surgeons database. Ann Thorac Surg 96:382–390CrossRef Crabtree TD, Kosinski AS, Puri V et al (2013) Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the society of thoracic surgeons database. Ann Thorac Surg 96:382–390CrossRef
6.
Zurück zum Zitat Rice TW, Mason DP, Murthy SC et al (2007) T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 133:317–324CrossRef Rice TW, Mason DP, Murthy SC et al (2007) T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 133:317–324CrossRef
7.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRef Amin MB, Greene FL, Edge SB, et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRef
8.
Zurück zum Zitat Guo W, Xiao HL, Ma Z et al (2014) Should stage T2 esophageal squamous cell carcinoma be subclassified? Ann Surg Oncol 21:2540–2545CrossRef Guo W, Xiao HL, Ma Z et al (2014) Should stage T2 esophageal squamous cell carcinoma be subclassified? Ann Surg Oncol 21:2540–2545CrossRef
9.
Zurück zum Zitat Duan J, Deng T, Ying G et al (2017) Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma. Dis Esophagus 30:1–7CrossRef Duan J, Deng T, Ying G et al (2017) Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma. Dis Esophagus 30:1–7CrossRef
10.
Zurück zum Zitat Seder CW, Mahon B, Hennon M et al (2018) Depth of muscularis propria invasion does not prognosticate survival in T2 esophageal adenocarcinoma. Anticancer Res 38:2195–2200PubMed Seder CW, Mahon B, Hennon M et al (2018) Depth of muscularis propria invasion does not prognosticate survival in T2 esophageal adenocarcinoma. Anticancer Res 38:2195–2200PubMed
11.
Zurück zum Zitat Rice TW, Zuccaro G Jr, Adelstein DJ et al (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65:787–792CrossRef Rice TW, Zuccaro G Jr, Adelstein DJ et al (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65:787–792CrossRef
12.
Zurück zum Zitat Nentwich MF, von Loga K, Reeh M et al (2014) Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg Off J Soc Surg Aliment Tract 18:242–249CrossRef Nentwich MF, von Loga K, Reeh M et al (2014) Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg Off J Soc Surg Aliment Tract 18:242–249CrossRef
13.
Zurück zum Zitat Endo M, Yoshino K, Kawano T et al (2000) Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 13:125–129CrossRef Endo M, Yoshino K, Kawano T et al (2000) Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 13:125–129CrossRef
14.
15.
Zurück zum Zitat Chen J, Liu S, Pan J et al (2009) The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio Thorac Surg 36:480–486CrossRef Chen J, Liu S, Pan J et al (2009) The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio Thorac Surg 36:480–486CrossRef
16.
Zurück zum Zitat Schwarz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 11:1384–1393CrossRef Schwarz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 11:1384–1393CrossRef
17.
Zurück zum Zitat Sancheti M, Fernandez F (2012) Management of T2 esophageal cancer. Surg Clin N Am 92:1169–1178CrossRef Sancheti M, Fernandez F (2012) Management of T2 esophageal cancer. Surg Clin N Am 92:1169–1178CrossRef
18.
Zurück zum Zitat Martin JT, Worni M, Zwischenberger JB et al (2013) The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. Ann Thorac Surg 95:453–458CrossRef Martin JT, Worni M, Zwischenberger JB et al (2013) The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. Ann Thorac Surg 95:453–458CrossRef
19.
Zurück zum Zitat Hollis AC, Quinn LM, Hodson J et al (2017) Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 116:1114–1122CrossRef Hollis AC, Quinn LM, Hodson J et al (2017) Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 116:1114–1122CrossRef
Metadaten
Titel
Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study
verfasst von
Dong Tian
Heng Huang
Yu-Shang Yang
Kai-Yuan Jiang
Xi He
Xiao-Guang Guo
Long-Qi Chen
Publikationsdatum
24.09.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 1/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05194-6

Weitere Artikel der Ausgabe 1/2020

World Journal of Surgery 1/2020 Zur Ausgabe

Innovative Surgical Techniques Around the World

Suture-Tool: A Mechanical Needle Driver for Standardized Wound Closure

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.